Kliniq

The project 'Kliniq' corresponds to a legitimate boutique eConsent platform for clinical trials (kliniq.co), but the submission contains high-risk signals including a likely pseudonym ('ThunderClaw'), hyperbolic and false traction claims ('most people have used my product'), and unrealistic audience definitions ('everyone'). While the underlying business exists and solves a real problem (clinical trial compliance), the submission quality is extremely low, and the claims are unverified or exaggerated. The 'marketcap' figure likely refers to a private valuation or is a misunderstanding, as no public token or stock matches the specific input data.